These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31496223)

  • 21. Imaging of alpha(v)beta(3) expression by a bifunctional chimeric RGD peptide not cross-reacting with alpha(v)beta(5).
    Zannetti A; Del Vecchio S; Iommelli F; Del Gatto A; De Luca S; Zaccaro L; Papaccioli A; Sommella J; Panico M; Speranza A; Grieco P; Novellino E; Saviano M; Pedone C; Salvatore M
    Clin Cancer Res; 2009 Aug; 15(16):5224-33. PubMed ID: 19671851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of ανβ3-mediated tumor expression with a 99mTc-labeled ornithine-modified RGD derivative during glioblastoma growth in vivo.
    Tsiapa I; Loudos G; Fragogeorgi EA; Bouziotis P; Psimadas D; Xanthopoulos S; Paravatou-Petsotas M; Palamaris L; Varvarigou AD; Karnabatidis D; Kagadis GC
    Cancer Biother Radiopharm; 2014 Dec; 29(10):444-50. PubMed ID: 25405951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Near-infrared fluorescence imaging of tumor integrin alpha v beta 3 expression with Cy7-labeled RGD multimers.
    Wu Y; Cai W; Chen X
    Mol Imaging Biol; 2006; 8(4):226-36. PubMed ID: 16791749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (64)Cu labeled AmBaSar-RGD2 for micro-PET imaging of integrin αvβ3 expression.
    Cai H; Li Z; Huang CW; Park R; Conti PS
    Curr Radiopharm; 2011 Jan; 4(1):68-74. PubMed ID: 22191616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of RGD-Containing Cyclic Peptides against αvβ3 Integrin.
    Wang Y; Xiao W; Zhang Y; Meza L; Tseng H; Takada Y; Ames JB; Lam KS
    Mol Cancer Ther; 2016 Feb; 15(2):232-40. PubMed ID: 26719578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome.
    Weller M; Nabors LB; Gorlia T; Leske H; Rushing E; Bady P; Hicking C; Perry J; Hong YK; Roth P; Wick W; Goodman SL; Hegi ME; Picard M; Moch H; Straub J; Stupp R
    Oncotarget; 2016 Mar; 7(12):15018-32. PubMed ID: 26918452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydro-Cy3-Mediated Detection of Reactive Oxygen Species In Vitro and In Vivo.
    Saeedi BJ; Chandrasekharan B; Neish AS
    Methods Mol Biol; 2019; 1982():329-337. PubMed ID: 31172482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosis.
    Cao J; Wan S; Tian J; Li S; Deng D; Qian Z; Gu Y
    Contrast Media Mol Imaging; 2012; 7(4):390-402. PubMed ID: 22649045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice.
    Chen K; Yap LP; Park R; Hui X; Wu K; Fan D; Chen X; Conti PS
    Amino Acids; 2012 Apr; 42(4):1329-37. PubMed ID: 21212998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RGD dendron bodies; synthetic avidity agents with defined and potentially interchangeable effector sites that can substitute for antibodies.
    McNerny DQ; Kukowska-Latallo JF; Mullen DG; Wallace JM; Desai AM; Shukla R; Huang B; Banaszak Holl MM; Baker JR
    Bioconjug Chem; 2009 Oct; 20(10):1853-9. PubMed ID: 20711425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GSH-Activated Light-Up Near-Infrared Fluorescent Probe with High Affinity to α
    Yuan Z; Gui L; Zheng J; Chen Y; Qu S; Shen Y; Wang F; Er M; Gu Y; Chen H
    ACS Appl Mater Interfaces; 2018 Sep; 10(37):30994-31007. PubMed ID: 30141897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indocyanine green-containing nanostructure as near infrared dual-functional targeting probes for optical imaging and photothermal therapy.
    Zheng X; Xing D; Zhou F; Wu B; Chen WR
    Mol Pharm; 2011 Apr; 8(2):447-56. PubMed ID: 21197955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative profiling of integrin αvβ3 on single cells with quantum dot labeling to reveal the phenotypic heterogeneity of glioblastoma.
    Wang T; Li G; Wang D; Li F; Men D; Hu T; Xi Y; Zhang XE
    Nanoscale; 2019 Oct; 11(39):18224-18231. PubMed ID: 31560005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia.
    Xu CS; Wang ZF; Huang XD; Dai LM; Cao CJ; Li ZQ
    J Transl Med; 2015 Mar; 13():95. PubMed ID: 25889845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glioblastomas require integrin αvβ3/PAK4 signaling to escape senescence.
    Franovic A; Elliott KC; Seguin L; Camargo MF; Weis SM; Cheresh DA
    Cancer Res; 2015 Nov; 75(21):4466-73. PubMed ID: 26297735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo noninvasive optical imaging of receptor-mediated RGD internalization using self-quenched Cy5-labeled RAFT-c(-RGDfK-)(4).
    Jin ZH; Razkin J; Josserand V; Boturyn D; Grichine A; Texier I; Favrot MC; Dumy P; Coll JL
    Mol Imaging; 2007; 6(1):43-55. PubMed ID: 17311764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Near-Infrared Confocal Laser Endomicroscopy Detects Colorectal Cancer via an Integrin αvβ 3 Optical Probe.
    Schulz P; Dierkes C; Wiedenmann B; Grötzinger C
    Mol Imaging Biol; 2015 Aug; 17(4):450-60. PubMed ID: 25622811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly selective in-vivo imaging of tumor as an inflammation site by ROS detection using hydrocyanine-conjugated, functional nano-carriers.
    Kim JY; Choi WI; Kim YH; Tae G
    J Control Release; 2011 Dec; 156(3):398-405. PubMed ID: 21787816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis.
    Chen X; Park R; Shahinian AH; Tohme M; Khankaldyyan V; Bozorgzadeh MH; Bading JR; Moats R; Laug WE; Conti PS
    Nucl Med Biol; 2004 Feb; 31(2):179-89. PubMed ID: 15013483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
    Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
    J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.